Sentinel lymph node involvement and a high Breslow index are independent factors of risk for early relapse of melanoma.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 18084679)

Published in Nuklearmedizin on January 01, 2007

Authors

J-P Willi1, M Matter, F Buchegger, C Antonescu, D Guggisberg, J-P Cerottini, J Krischer, R Braun, A Marie Kurt, B Roche, R Lemoine, D Rimoldi, F J Lejeune, D Liénard, A Bischof Delaloye

Author Affiliations

1: Service de Médecine Nucléaire, University Hospital Geneva, Rue Mucheli-du-Crest 24, 1211 Genève 14, Switzerland. jean-pierre.willi@hcuge.ch

Articles by these authors

The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47

Inhibition of death receptor signals by cellular FLIP. Nature (1997) 9.58

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science (1996) 6.02

Recent results of elective open cholecystectomy in a North American and a European center. Comparison of complications and risk factors. Ann Surg (1992) 3.91

Sunscreen use and duration of sun exposure: a double-blind, randomized trial. J Natl Cancer Inst (1999) 3.75

Macromolecular trafficking indicated by localization and turnover of sucrose transporters in enucleate sieve elements. Science (1997) 3.43

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer (1999) 3.19

APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med (1998) 3.17

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J Exp Med (1998) 3.04

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med (1999) 2.98

Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. J Immunol (1998) 2.68

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol (1996) 2.61

Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma. Nat Med (1998) 2.42

Assessing the New York City involuntary outpatient commitment pilot program. Psychiatr Serv (2001) 2.41

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J Clin Oncol (1998) 2.39

Sugar transporters in higher plants--a diversity of roles and complex regulation. Trends Plant Sci (2000) 2.38

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol (1992) 2.12

Can fixation instability improve text perception during eccentric fixation in patients with central scotomas? Br J Ophthalmol (2004) 2.09

Treatment of low subcondylar fractures--a 5-year retrospective study. Int J Oral Maxillofac Surg (2013) 2.00

A ribonuclease from Physarum. Biochemical properties and synthesis in the mitotic cycle. Biochim Biophys Acta (1969) 1.97

Ascaris haemoglobin is a nitric oxide-activated 'deoxygenase'. Nature (1999) 1.93

Structure of ribosomal DNA in Physarum polycephalum. J Mol Biol (1976) 1.92

Impaired vascular contractility and blood pressure homeostasis in the smooth muscle alpha-actin null mouse. FASEB J (2000) 1.91

Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int J Cancer (1995) 1.81

Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst (1989) 1.72

RNA of Physarum. I. Preparation and properties. Exp Cell Res (1971) 1.70

Red fingers syndrome in patients with HIV and hepatitis C infection. Lancet (1996) 1.66

Mechanistic ontology and contextualistic epistemology: A contradiction within behavior analysis. Behav Anal (1994) 1.65

Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice. J Exp Med (1983) 1.63

Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J Exp Med (2000) 1.62

Tubulin genes of Trypanosoma brucei: a tightly clustered family of alternating genes. Proc Natl Acad Sci U S A (1983) 1.61

Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice. J Control Release (2010) 1.58

Time sequence of DNA replication in Physarum. Biochim Biophys Acta (1969) 1.56

Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J Clin Invest (1995) 1.55

The replication of ribosomal DNA in Physarum polycephalum. Eur J Biochem (1977) 1.55

A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med (1990) 1.53

Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras. Science (1990) 1.53

A conserved stem-loop structure in the 3' untranslated region of procyclin mRNAs regulates expression in Trypanosoma brucei. Proc Natl Acad Sci U S A (1994) 1.52

Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-alpha2a (IFNalpha) and interleukin 2 (IL-2) with or without cisplatin. Eur J Cancer (2002) 1.51

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience. Ann Surg (1996) 1.51

Control of polyadenylation and alternative splicing of transcripts from adjacent genes in a procyclin expression site: a dual role for polypyrimidine tracts in trypanosomes? Nucleic Acids Res (1994) 1.47

Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients. Cancer Res (2000) 1.47

Accurate polyadenylation of procyclin mRNAs in Trypanosoma brucei is determined by pyrimidine-rich elements in the intergenic regions. Mol Cell Biol (1994) 1.45

Identification of a mannitol transporter, AgMaT1, in celery phloem. Plant Cell (2001) 1.44

Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol (2000) 1.44

Coley's vaccine and TNF therapy. Nature (1992) 1.40

Redistribution of intracellular Ca2+ stores during phagocytosis in human neutrophils. Science (1994) 1.39

Anesthesiologists' management of isolated limb perfusion with "high-dose" tumor necrosis factor alpha. Anesthesiology (1993) 1.39

[Adult to adult living-related liver transplantation. The Paul-Brousse Hospital preliminary experience]. Gastroenterol Clin Biol (2001) 1.38

Brain stem gliomas: a classification system based on magnetic resonance imaging. Pediatr Neurosurg (1992) 1.36

Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer (2000) 1.35

Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. J Clin Invest (1994) 1.34

Polyamine-mediated phosphorylation of a nucleolar protein from Physarum polycephalum that stimulates rRNA synthesis. Proc Natl Acad Sci U S A (1979) 1.34

Cloning and expression of a hexose transporter gene expressed during the ripening of grape berry. Plant Physiol (1999) 1.34

Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys (1993) 1.34

Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity. Cancer Res (2001) 1.31

Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients. J Immunol (2000) 1.31

Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life. Proc Natl Acad Sci U S A (2001) 1.31

CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients. Eur J Immunol (1999) 1.26

Acetic acid increases stability of silage under aerobic conditions. Appl Environ Microbiol (2003) 1.26

Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. Br Med J (Clin Res Ed) (1982) 1.25

Maternal transmission of immunity to Eimeria maxima: enzyme-linked immunosorbent assay analysis of protective antibodies induced by infection. Infect Immun (1994) 1.25

Confirmed angiosarcoma: prognostic factors and outcome in 50 prospectively followed patients. Sarcoma (2000) 1.24

Incongruous stimulus pairing and conditional discrimination training: effects on relational responding. J Exp Anal Behav (1997) 1.24

Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases. J Immunol (2001) 1.24

The organisation of genes for transfer RNA and ribosomal RNA in amoebae and plasmodia of Physarum polycephalum. Eur J Biochem (1977) 1.24

Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group. N Engl J Med (1996) 1.24

Direct detection of a BRAF mutation in total RNA from melanoma cells using cantilever arrays. Nat Nanotechnol (2013) 1.24

Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNF alpha). Int J Cancer (1994) 1.22

Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology (2000) 1.22

Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids. Cancer Res (1987) 1.22

Polysome patterns and protein synthesis during the mitotic cycle of Physarum polycephalum. Nature (1966) 1.21

Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. J Clin Oncol (1997) 1.20

Human cytomegalovirus replicates in primary human bone marrow cells. J Gen Virol (1986) 1.18

The gene for the 26 S rRNA in Physarum contains two insertions. FEBS Lett (1979) 1.17

Structure of the extrachromosomal ribosomal RNA chromatin of Physarum polycephalum. J Mol Biol (1987) 1.16

Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. Cancer Res (1983) 1.16

Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence. Nuklearmedizin (2009) 1.15

Sequential temporal replication of DNA in Physarum polycephalum. Proc Natl Acad Sci U S A (1965) 1.14

Cloning of a carcinoembryonic antigen gene family member expressed in leukocytes of chronic myeloid leukemia patients and bone marrow. Cancer Res (1990) 1.14

Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593. J Clin Oncol (1998) 1.14

Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies. J Clin Invest (1986) 1.13

The human Ia-associated invariant chain is synthesized in Ia-negative B cell variants and is not expressed on the cell surface of both Ia-negative and Ia-positive parental cells. J Immunol (1985) 1.13

Clinical applications of TNF-alpha in cancer. Curr Opin Immunol (1998) 1.12

Chorioretinal vascular abnormalities associated with angioid streaks and pseudoxanthoma elasticum. Arch Ophthalmol (1998) 1.11

Immunophotodiagnosis of colon carcinomas in patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen. Proc Natl Acad Sci U S A (1992) 1.11

The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up. Diabetologia (2010) 1.10

Anti-MAGE-3 antibody 57B and anti-MAGE-1 antibody 6C1 can be used to study different proteins of the MAGE-A family. Int J Cancer (2000) 1.10

Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC Melanoma Cooperative Group. Eur J Cancer (1998) 1.10